Licofelone

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLicofelone
Drug Alias Name利克飞龙licofelona利考非隆licofelonumML-3000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-1 inhibitorsArachidonate 5-lipoxygenase inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Arachidonate 5-lipoxygenaseCyclooxygenase-1
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSumitomo DainipponTeva Pharmaceutical Industries Ltd
Active IndicationsN/A
Inactive IndicationsOsteoarthritis

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank